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EFFECT OF OCCLUSIVE DRESSING ON THE LOCAL ADMINISTEATION OF
5-FLUOROURACIL TO SUPERFICIAL BASAL CELL CARCINOMA*
HOWARD L. STOLL, JR., M.D. AND EDMUND KLEIN, M.D.
In previous studies (1, 2, 3, 4) local adminis-
tration of 5-Fluorouracilt (5-EU) was found to
have marked effects upon the natural course of
single and multiple basal cell epitheliomas.
When 5-FU cream was applied to large areas
of superficial basal cell carcinoma the concen-
tration of 5-FU did not seem to affect greatly
the degree of tumor regression (2). In a later
more systematic study (4) a statistically sig-
nificant difference in the effects of four concen-
trations of 5-FU cream (0.5%, 0.5%, 5.0%,
20.0%) upon tumor regression could not be
demonstrated. However, the mode of adminis-
tration did seem to influence greatly the pro-
portion of tumors which underwent resolution.
A larger number of tumors regressed when the
study sites were covered with plastic occlusive
dressings than when the sites were left un-
covered (2). The present study was carried out
to re-examine and evaluate the impression that
the effect of topical 5-EU on superficial basal
cell carcinomas is significantly influenced by
the use of a plastic occlusive dressing.
MATERIALS AND METHODS
The seven patients in this study have multiple
superficial basal cell carcinomas. L.A., is a 55
year old male, who had superficial basal cell
carcinomas scattered over the trunk, and two
nodular ulcerated basal cell carcinomas on the
nose. J.L., a 50 year old white male, had a nodular
basal cell carcinoma on the left temple and six
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superficial basal cell carcinomas on the trunk.
a 58 year old male who had multiple basal
cell carcinomas on the trunk, neck and upper arms,
had received x-ray therapy for cystic acne in
these areas 20 years previously. B.L., an 86 year
old female, had multiple superficial basal cell car-
cinomas on the trunk and lower extremities. J.M.,
a 46 year old female, had multiple superficial
basal cell carcinomas on the head, trunk, and
extremities associated with the basal cell nevus
syndrome. R.W., a 56 year old white male, had
multiple superficial basal cell carcinomas on the
anterior abdomen and lower back. These areas
had been exposed to multiple x-ray doses 30 years
ago during treatment for presumed metastatic
testicular cancer. D.W., a 29 year old female, had
multiple superficial basal cell carcinomas on the
trunk and head, associated with the basal cell
nevus syndrome.
Four superficial basal cell carcinomas on each
patient were investigated in this study. Discrete
lesions of similar chnical characteristics were se-
lected and the diagnosis was confirmed by biopsy
of all lesions. Each lesion was outlined and num-
bered with skin coloring paint to ensure identifi-
cation of the respective lesions during the course
of the investigation and subsequent observation
period.
The four lesions on each patient were treated
in the following manner: 20.0% 5-EU in Acid
Mantle Cream was applied to two lesions, one
being covered with an occlusive dressing of poly-
ethylene plastic, and one being left uncovered;
5.0% 5-FU Acid Mantle Cream was applied to the
other two lesions, one being covered with an oc-
clusive dressing, and one being left uncovered. All
four lesions on each patient were studied concur-
rently. The agents and dressings were applied
daily for 2 weeks (15 days). The areas were ob-
served and photographed at weekly intervals
during the course of 5-FU administration and for
four weeks thereafter, at weekly to bi-weekly inter-
vals. The presence of residual tumor was deter-
mined by biopsy four weeks after the course of
5-FU had been completed.
The study sites were observed and photographed
periodically. Repeat biopsies were carried out in a
few selected study sites when the clinical indica-
tions of the presence or absence of tumor appeared
to change during the observation period. The
study was terminated when the sites became stable
and unchanging as judged by inspection and bi-
opsy in selected instances. Stabilization occurred
as indicated: patient L.A. seventeenth week of
study; patient J.L. twenty-seventh week; patient
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A.B. eighteenth week; patient B.L. eighteenth
week; patient J.M. sixteenth week; patient R.W.
sixteenth week; patient D.W. nineteenth week.
RESULTS
The reactions of the basal cell carcinomas to
topical administration of 5-FU were similar to
the reactions previously reported (1, 2, 3, 4).
The incidences of tumor regression and persist-
ence are summarized in Table I.
50% 5-FU and 20.0% 5-FU Creams
with Occlusion
The 5.0% 5-FU cream and the 20.0% 5-FU
cream produced about the same degree of re-
actions under occlusive dressings. The tumor
sites were eroded or ulcerated after two weeks
of application and, in some cases, the erosion
was larger than the tumor. Extension of ulcera-
tion beyond the apparent extent of tumor oc-
curred in sites treated with 5.0% and 20.0%
5-FU in three patients. In one of these cases,
and in two of the remaining four eases, the
extent of ulceration was larger or deeper in the
site to which 20.0% 5-FU cream had been ap-
plied than in the site to which 5.0% 5-FU
cream had been applied. In two sites to which
5.0% 5-FU had been applied, crusts had
formed over part or all of the ulcerated area
by the end of the second week of application;
in those sites to which 20.0% 5-FE cream had
been applied no crust had formed by the end
of the second week of application. Following
discontinuation of the application of 5.0% and
20.0% 5-FE cream under occlusion, crusts
formed on the ulcerated sites. Exfoliation of
the crust within one or two weeks left a slightly
erytheniatous atrophic scar which became
somewhat hypopigmented within a few weeks.
The size of the atrophic scar was the same as or
only slightly larger than the original size of the
tumor.
Histological examination following cessation
of the apphcation of 5.0% 5-FE cream with
occlusion showed tumor persistence in two in-
stances and absence of tumor in five instances.
All five of the sites where tumor disappearance
had been confirmed by punch biopsy, remained
free of tumor for the duration of the study. Of
the two sites at which tumor persistence was
demonstrated by punch biopsy, one continued
to show multiple small residual tumor nodules
tround the edge. The other site, which showed
L.A.
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D.W.
Tumor
resolu-
tion
Tumor
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= tumor persistence; —= tumor resolu-
tion).
tumor persisting one month after cessation of
applications, became macular by the tenth
week of the study, and remained free of tumor
for the duration of observation (through the
nineteenth week). Histological examination
following cessation of the application of 20.0%
5-FE cream with occlusion showed persistent
tumor in one instance, and absence of tumor in
six instances. All six of those sites at which dis-
appearance of tumor had been confirmed by
punch biopsy, remained free of tumor for the
duration of the observation period. The one
site, where tumor persistence had been estab-
lished by punch biopsy, continued to show mul-
tiple small papules of residual tumor around
the edge.
5.0% 5-FU and 20.0% 5-FU Creams
without Occlusion
The degree of reaction in the basal cell car-
cinomas was much less marked without occlu-
sion than with occlusion. The 5.0% 5-FE cream
without occlusion produced erythema in all the
tumors, but erosion or ulceration in only two
tumors. The erythema faded within a few
weeks. Following cessation of applications of
5.0% 5-FE cream without occlusion, histologic
examination showed tumor persistence in four
sites and absence of tumor in three. All of the
four sites which showed tumor persistence on
histologic examination, continued to show
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papular tumors, clinically. Of the three sites
which became microscopically free of malignant
cells, two sites remained free of tumor, whereas
the third became papular and revealed per-
sistence or recurrence of basal cell carcinoma
when biopsy was repeated in the sixteenth week
of the study.
Application of the 20.0% 5-FTJ cream with-
out occlusion produced a more intense reaction
in the tumors than the 5.0% 5-FIJ cream with-
out occlusion, but less reaction than the 5.0%
or the 20.0% 5-FU creams with occlusion. Ap-
plication of the 20.0% cream without occlusion
caused erythema and erosion or ulceration in
four of the seven tumors. Crusting occurred by
the end of the second week of application in
three of these four tumors.
Histological examination following the ap-
plication of the 20.0% 5-FU cream without oc-
elusion showed tumor persistence in three in-
stances and absence of tumor in four instances.
The three sites in which tumor persistence was
confirmed by biopsy continued to show tumor,
and the four sites that had shown tumor dis-
appearance by biopsy remained free of tumor
for the duration of the observation period.
DISCUSSION
The application of an occlusive plastic dress-
ing had a marked effect upon disappearance
of superficial basal cell carcinomas in this
study. In a previous study (2) observations
on two patients in whom 5-FIJ cream had been
studied with and without occlusion, had indi-
cated that the use of an occlusive dressing in-
creased the number of tumor resolutions. The
suggestion that "occlusion enhances the anti-
tumor effect" which was made at that time, has
been confirmed in the present study.
Analysis of tumor resolution after applica-
tion of 5.0% and 20.0% 5-FU cream with and
without occlusion, can be made by examina-
tion of the Table. If the sites studied with
5.0% 5-FU cream, with and without occlusion,
and the sites studied with 20.0% 5-FU cream,
with and without occlusion are paired, there
are 14 pairs of results. That is, in each pa-
tient there are 2 pairs, 5.0% 5-FU cream with
and without occlusion, and 20.0% 5-FU cream
with and without occlusion. There are 8 pairs
in which the results are identical with regard
to tumor disappearance. In the other six pairs
the results in each of the paired sites are
different; that is, in one site the tumor re-
gressed, and in the other it did not. In each
of these 6 pairs, the site in which the tumor
disappeared was the occluded site, and the site
in which the tumor did not disappear was the
nonocciuded site. The odds of six such pairs
behaving identically is one in thirty-two which
is significant at the 34o level of confidence.
SUMMARY
The topical application of 5.0% and 20.0%
5-FU cream with and without occlusive dress-
ing, for two weeks, to 28 superficial basal cell
carcinomas, produced changes in the natural
course of the tumors. The incidence of tumor
regression was significantly higher with occlu-
sion than non-occlusion of the sites of appli-
cation of 5.0% and 20.0% 5-FTJ cream.
REFERENCES
1. Klein, E., Stoll, H. L., Jr., Milgrom, H., Case,
R. W., Traenkle, H. L., Graham, S, Laor, Y.
and Helm, F.: Tumors of the skin IV. Dou-
ble blind study on effects of local admin-
istration of anti-tumor agents in basal cell
carcinoma. J. Invest. Derm., 44: 351, 1965.2. Klein, E., Stoll, H. L., Jr., Milgrom, H.,
Traenkle, H. L., Case, R. W., Laor, Y., Helm,F. and Nadel, R. W.: Tumors of the skin
V. Local administration of anti-tumor agents
to multiple superficial basal cell carcinomas.
J. Invest. Derm., 45: 489, 1965.3. Klein, E., Stoll, H. L., Jr., Milgrom, H.,
Traenkle, H. L., Graham, S. and Helm, F.:
Tumors of the skin VI. Study on effects of
local administration of 5-fluorouracil in basal
cell carcinoma. J. Invest. Derm., 47: 22, 1966.
4. Stall, H. L., Jr., Klein, E. and Case, R. W.:
Tumors of the skin VIII. Effects of varying
the concentration of locally administered 5-
fluorouracil on basal cell carcinoma. J. In-
vest. Derm., 49: 219, 1967.
